ConductScience.org, home

Paper23602467

Hepatitis C virus core antigen assay: can we think beyond convention in resource limited settings?

Chakravarti A and 3 others. Braz J Infect Dis, 2013. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Hepatitis C virus core antigen assay: can we think beyond convention in resource limited settings? Papers, record 23602467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23602467

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatitis C virus core antigen assay: can we think beyond convention in resource limited settings?
PubMed
Journal
Braz J Infect Dis
PubMed
Year
2013
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2022-09-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chakravarti AAnita
2Chauhan MSMayank S
3Dogra GGaurav
4Banerjee SSayantan

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HepacivirusMajor topic
Hepatitis CMajor topic
Hepatitis C AntigensMajor topic
RNA, ViralMajor topic
Viral Core ProteinsMajor topic
Humans
India
Predictive Value of Tests
Reproducibility of Results
Reverse Transcriptase Polymerase Chain Reaction
Sensitivity and Specificity
Viral Load

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116023971Use of virologic assays in the diagnosis and management of hepatitis C virus infection.Clin Liver Dis2005https://conductscience.org/library/papers/16023971PubMed
212433562Alternatives to nucleic acid testing in the blood transfusion service.Lancet2002https://conductscience.org/library/papers/12433562PubMed
312049856The UK blood transfusion service: over a (patent) barrel?Lancet2002https://conductscience.org/library/papers/12049856PubMed
415071017Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.J Clin Microbiol2004https://conductscience.org/library/papers/15071017PubMed
57595353Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group.J Gen Virol1995https://conductscience.org/library/papers/7595353PubMed
617569145Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China.World J Gastroenterol2007https://conductscience.org/library/papers/17569145PubMed
715653411The role of core antigen detection in management of hepatitis C: a critical review.J Clin Virol2005https://conductscience.org/library/papers/15653411PubMed
817163874Distribution of hepatitis C virus genotypes in beta-thalassaemic patients from Northern India.Transfus Med2006https://conductscience.org/library/papers/17163874PubMed
915057920Diagnosis, management, and treatment of hepatitis C.Hepatology2004https://conductscience.org/library/papers/15057920PubMed
1016081925Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection.J Clin Microbiol2005https://conductscience.org/library/papers/16081925PubMed
1116327131Prevalence of hepatitis C and B viral markers in patients with chronic liver disease: a study from Northern India.Indian J Med Microbiol2005https://conductscience.org/library/papers/16327131PubMed
1212085367Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.Hepatology2002https://conductscience.org/library/papers/12085367PubMed
1320351215New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification.J Clin Microbiol2010https://conductscience.org/library/papers/20351215PubMed
1420233674Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients.J Clin Virol2010https://conductscience.org/library/papers/20233674PubMed
1572251Acute and chronic hepatitis revisited. Review by an international group.Lancet1977https://conductscience.org/library/papers/72251PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
39497140Efficacy of 8-week daclatasvir-sofosbuvir regimen in chronic hepatitis C: a systematic review and meta-analysis.Virol J2024https://conductscience.org/library/papers/39497140PubMed
35535106Laboratory Evaluation of Hepatitis C Virus Infection in Patients Undergoing Hemodialysis from North East India.J Clin Exp Hepatol2022https://conductscience.org/library/papers/35535106PubMed
33788295HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection.J Clin Lab Anal2021https://conductscience.org/library/papers/33788295PubMed
33605377Improving Diagnosis of Hepatitis C Virus Infection Using Hepatitis C Core Antigen Testing in a Resource-Poor Setting.Rev Soc Bras Med Trop2021https://conductscience.org/library/papers/33605377PubMed
33187498Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients.BMC Nephrol2020https://conductscience.org/library/papers/33187498PubMed
30855495HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b.Medicine (Baltimore)2019https://conductscience.org/library/papers/30855495PubMed
27493460Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.J Clin Exp Hepatol2016https://conductscience.org/library/papers/27493460PubMed
26900280Hepatobiliary Quiz (Answers)-16 (2015).J Clin Exp Hepatol2015https://conductscience.org/library/papers/26900280PubMed
26628840Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015.J Clin Exp Hepatol2015https://conductscience.org/library/papers/26628840PubMed
25755549Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.J Clin Exp Hepatol2014https://conductscience.org/library/papers/25755549PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23602467

GET https://conductscience.org/api/papers/v1/23602467/authors